Douglas A. Bergman

591 total citations
15 papers, 492 citations indexed

About

Douglas A. Bergman is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Douglas A. Bergman has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Douglas A. Bergman's work include Click Chemistry and Applications (8 papers), HIV/AIDS drug development and treatment (6 papers) and Protein Structure and Dynamics (5 papers). Douglas A. Bergman is often cited by papers focused on Click Chemistry and Applications (8 papers), HIV/AIDS drug development and treatment (6 papers) and Protein Structure and Dynamics (5 papers). Douglas A. Bergman collaborates with scholars based in Australia, New Zealand and United States. Douglas A. Bergman's co-authors include David P. Fairlie, Darren R. March, Giovanni Abbenante, Donald J. Winzor, Robert C. Reid, Jennifer L. Martin, Paul F. Alewood, E. C. Foulkes, Joel D. A. Tyndall and Christina L. L. Chai and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Analytical Biochemistry.

In The Last Decade

Douglas A. Bergman

15 papers receiving 471 citations

Peers

Countries citing papers authored by Douglas A. Bergman

Since Specialization

Citations

This map shows the geographic impact of Douglas A. Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas A. Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas A. Bergman more than expected).

Fields of papers citing papers by Douglas A. Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas A. Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas A. Bergman. The network helps show where Douglas A. Bergman may publish in the future.

Co-authorship network of co-authors of Douglas A. Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas A. Bergman. A scholar is included among the top collaborators of Douglas A. Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas A. Bergman. Douglas A. Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Synthesis, Stability, Antiviral Activity, and Protease-Bound Structures of Substrate-Mimicking Constrained Macrocyclic Inhibitors of HIV-1 Protease 2000 ·Journal of Medicinal Chemistry ·Joel D. A. Tyndall, Robert C. Reid, David Tyssen, Darren Jardine, (unknown), Margaret R. Passmore, Darren R. March, Leonard K. Pattenden, Douglas A. Bergman, Dianne Alewood, Shuhong Hu, Paul F. Alewood, Christopher J. Birch, Jennifer L. Martin, David P. Fairlie	51
2	Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes: Implications for Drug Design and Polypeptide Processing 2000 ·Journal of Medicinal Chemistry ·David P. Fairlie, Joel D. A. Tyndall, Robert C. Reid, A. K. Wong, Giovanni Abbenante, M.J. Scanlon, Darren R. March, Douglas A. Bergman, Christina L. L. Chai, Brendan A. Burkett	133
3	Molecular Recognition of Macrocyclic Peptidomimetic Inhibitors by HIV-1 Protease^, 1999 ·Biochemistry ·Jennifer L. Martin, Jakob Begun, Aaron Schindeler, W. A. Wickramasinghe, Dianne Alewood, Paul F. Alewood, Douglas A. Bergman, Ross I. Brinkworth, Giovanni Abbenante, Darren R. March, Robert C. Reid, David P. Fairlie	36
4	Simple cis-epoxide-based inhibitors of HIV-1 protease 1997 ·Bioorganic & Medicinal Chemistry Letters ·Andrew D. Abell, (unknown), Douglas A. Bergman, David P. Fairlie	6
5	Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease 1996 ·Bioorganic & Medicinal Chemistry Letters ·Giovanni Abbenante, Douglas A. Bergman, (unknown), Darren R. March, Robert C. Reid, (unknown), Ian W. James, (unknown), (unknown), Martin J. Stoermer, David P. Fairlie	11
6	Substrate-Based Cyclic Peptidomimetics of Phe-Ile-Val That Inhibit HIV-1 Protease Using a Novel Enzyme-Binding Mode 1996 ·Journal of the American Chemical Society ·Darren R. March, Giovanni Abbenante, Douglas A. Bergman, Ross I. Brinkworth, Wasantha A. Wickramasinghe, Jakob Begun, Jennifer L. Martin, David P. Fairlie	67
7	Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease. 1995 ·Journal of the American Chemical Society ·Giovanni Abbenante, Darren R. March, Douglas A. Bergman, (unknown), (unknown), (unknown), Jennifer L. Martin, David P. Fairlie	47
8	Kinetic properties of HIV-1 protease produced by total chemical synthesis with cysteine residues replaced by isosteric L-?-amino-n-butyric acid 1995 ·Letters in Peptide Science ·Douglas A. Bergman, Dianne Alewood, Paul F. Alewood, John L. Andrews, Ross I. Brinkworth, (unknown), Stephen B. H. Kent	11
9	A novel thioether linker: Chemical synthesis of a HIV-1 protease analogue by thioether ligation 1995 ·Tetrahedron Letters ·(unknown), (unknown), Douglas A. Bergman, Paul F. Alewood	41
10	Inorganic Mercury Absorption in Mature and Immature Rat Jejunum: Transcellular and Intercellular Pathways in Vivo and in Everted Sacs 1993 ·Toxicology and Applied Pharmacology ·E. C. Foulkes, Douglas A. Bergman	33
11	Effects of thermodynamic nonideality on the kinetics of ester hydrolysis by α-chymotrypsin: A model system with preexistence of the isomerization equilibrium 1989 ·Archives of Biochemistry and Biophysics ·Douglas A. Bergman, Keith E. Shearwin, Donald J. Winzor	14
12	Space-filling effects of inert solutes as probes for the detection and study of substrate-mediated conformational changes by enzyme kinetics: Theoretical considerations 1989 ·Journal of Theoretical Biology ·Douglas A. Bergman, Donald J. Winzor	14
13	Thermodynamic nonideality in enzyme catalysis 1989 ·European Journal of Biochemistry ·Douglas A. Bergman, Donald J. Winzor	12
14	Quantitative affinity chromatography: Increased versatility of the technique for studies of ligand binding 1986 ·Analytical Biochemistry ·Douglas A. Bergman, Donald J. Winzor	14
15	Anomalous electrophoretic behavior of creatine kinase: A thiol-dependent isomeric system with migration subject to kinetic control 1980 ·Archives of Biochemistry and Biophysics ·(unknown), Douglas A. Bergman, (unknown), Donald J. Winzor	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact